Shared signaling pathways and comprehensive therapeutic approaches among diabetes complications

Moein Ebrahimi(Shahid Beheshti University of Medical Sciences), Nader Sheibani, Saeed Parsa(Shahid Beheshti University of Medical Sciences), Hamid Ahmadieh(Shahid Beheshti University of Medical Sciences), Christine M. Sorenson(University of Wisconsin–Madison), Sare Safi(Shahid Beheshti University of Medical Sciences), Soroor Advani(Shahid Beheshti University of Medical Sciences), Mozhgan Rezaei Kanavi(Shahid Beheshti University of Medical Sciences)
Frontiers in Medicine
January 8, 2025
10.3389/fmed.2024.1497750
Cited by 10

Related Papers

Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017
|The Lancet|2018|14k
Global, regional, and national incidence, prevalence, and years lived with disability for 328 diseases and injuries for 195 countries, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016
|The Lancet|2017|13.5k
Global, regional, and national comparative risk assessment of 84 behavioural, environmental and occupational, and metabolic risks or clusters of risks for 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017
|The Lancet|2018|5k
Global, regional, and national comparative risk assessment of 84 behavioural, environmental and occupational, and metabolic risks or clusters of risks, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016
|The Lancet|2017|2.4k
Trends in prevalence of blindness and distance and near vision impairment over 30 years: an analysis for the Global Burden of Disease Study
|The Lancet Global Health|2020|1.3k